Covered recipient · General Payments record
SAMI IBRAHIMI
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2018–2024
$22,429.29
- Reported across 42 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $3,840.00 | 2 |
| Travel and Lodging | $804.96 | 1 |
| Food and Beverage | $417.71 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Genmab U.S., Inc. | $2,556.54 | 5 |
| ABBVIE INC. | $2,213.51 | 2 |
| Mallinckrodt Hospital Products Inc. | $144.35 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $82.61 | 1 |
| RECORDATI_RARE_DISEASES_INC. | $51.01 | 2 |
| GlaxoSmithKline, LLC. | $14.65 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $2,200.00 | 02/09/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1103135495 | CMS |
| ABBVIE INC. | $13.51 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103963549 | CMS |
| Genmab U.S., Inc. | $804.96 | 11/05/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1126831776 | CMS |
| Genmab U.S., Inc. | $28.19 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126831778 | CMS |
| Genmab U.S., Inc. | $55.20 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126831780 | CMS |
| Genmab U.S., Inc. | $28.19 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126831782 | CMS |
| Genmab U.S., Inc. | $1,640.00 | 12/13/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1126831774 | CMS |
| GlaxoSmithKline, LLC. | $14.65 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116367491 | CMS |
| Mallinckrodt Hospital Products Inc. | $144.35 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145085614 | CMS |
| Novartis Pharmaceuticals Corporation | $82.61 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086930455 | CMS |
| RECORDATI_RARE_DISEASES_INC. | $27.54 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139163324 | CMS |
| RECORDATI_RARE_DISEASES_INC. | $23.47 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139163326 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.